Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC1581641

Enzo Life Sciences PKI (14-22) amide (myristoylated) (0.5 mg) CAS: 201422-03-9
SDP

Supplier:  Enzo Life Sciences BMLP2100500

Encompass_Preferred

PKA inhibitor. Heat-stable protein kinase inhibitor (PKI) peptide sequence (14-22). N-terminus is myristoylated to increase cell membrane permeability. The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA) with Ki=36 nM. This product is a useful tool for studying PKA in cellular systems. Alternative Name: cAMP dependent protein kinase inhibitor (14 22) amide (myristoylated). Formula: C53H100N20O12. MW: 1209.5. CAS: 201422-03-9. Formulation: Lyophilized. Trifluoroacetate salt. Purity: ≥95% (HPLC). Sequence N-myristoyl-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2. Appearance: Solid. Solubility: Soluble to at least 1mg/ml in water. Long Term Storage: -20°C. Handling: Protect from moisture.

Catalog No. NC1581641


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.